Table 1.
Aptamers against biomarker | Nanocarriers | Detection method | Oligos | Linear dynamic range (LDR) | Limit of detection (LOD) |
Detection model | Ref. |
---|---|---|---|---|---|---|---|
CA 19–9 | None | Fluorescence | DNA |
Kd value 20.05 ± 3.02 nmol/L |
– | Not tested in serum | [18] |
CEA | Zirconium metal-organic framework of silver nanoclusters (AgNCs) | ECL and SPR | DNA | 1.0–250 ng/mL | 0.3 ng/ml | Human serum | [90] |
CEA | Ru@SiO2 − AuNPs | ECL | DNA | 5.0–50,000 fg/mL | 1.52 fg/ml | Human serum | [91] |
CEA | CdS-GR-AuNPs | ECL | DNA | 0.01–10.0 ng/ml | 3.8 pg/ml | Human serum | [92] |
IL-6 | Carbon nanotube | ECL | RNA | 1 pg/mL to 10 ng/mL | 1 pg/ml | Human serum | [33] |
MMP-9 | None | SPR | DNA | – | 0.56 ng/ml | Commercial serum | [29] |
VEGF | Quantum dots | Fluorescence | DNA | – | 50 pmol/L | Human serum | [34] |
VEGF | None | ECL | DNA | 50 pmol/L to 0.15 nmol/L | 5 pmol/L (190 pg/mL) | 50% serum | [35] |
VEGF | Carbon–gold nanocomposite | ECL | DNA | 10 to 300 pg/ml | 1 pg/ml | Human serum | [48] |